Vertex Pharmaceuticals Ratios (2009-2025) | VRTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)	88.85%	87.29%	88.08%	88.06%	88.28%	88.08%	87.60%	87.70%	88.76%	87.62%	87.17%	85.38%	87.27%	85.94%	85.84%	85.46%	86.90%	86.25%	86.52%	85.39%
EBT Margin (Quarter)	47.61%	-2.46%	54.57%	42.02%	45.52%	46.64%	50.40%	46.76%	37.54%	46.59%	47.48%	45.58%	47.54%	-128.18%	44.16%	39.03%	26.37%	43.28%	42.22%	41.72%
EBIT Margin (Quarter)	51.49%	-2.11%	53.15%	42.35%	49.63%	50.37%	48.27%	44.88%	32.80%	41.17%	41.80%	39.26%	42.35%	-132.85%	40.27%	35.23%	22.75%	38.83%	38.56%	37.80%
EBITDA Margin (Quarter)	51.49%	-2.11%	53.15%	42.35%	49.63%	50.37%	48.27%	44.88%	32.80%	41.17%	41.80%	39.26%	42.35%	-132.85%	40.27%	35.23%	22.75%	38.83%	38.56%	37.80%
Operating Margin (Quarter)	51.49%	-2.11%	53.15%	42.35%	49.63%	50.37%	48.27%	44.88%	32.80%	41.17%	41.80%	39.26%	42.35%	-132.85%	40.27%	35.23%	22.75%	38.83%	38.56%	37.80%
Net Margin (Quarter)	37.88%	3.74%	42.94%	37.16%	36.33%	36.90%	39.86%	35.56%	29.47%	36.73%	41.69%	38.48%	40.87%	-135.83%	37.71%	31.35%	23.33%	34.84%	35.20%	37.34%
FCF Margin (Quarter)	49.30%	-13.92%	44.09%	45.03%	42.56%	49.47%	38.61%	45.37%	36.12%	43.11%	49.44%	7.01%	46.02%	-144.49%	46.97%	16.90%	28.09%	31.28%	37.04%	10.93%
Efficiency
Inventory Average (Quarter)	0.29B	0.31B	0.33B	0.34B	0.35B	0.35B	0.38B	0.42B	0.50B	0.57B	0.65B	0.71B	0.78B	0.86B	1.00B	1.14B	1.28B	1.43B	1.56B	1.66B
Assets Average (Quarter)	11.93B	12.17B	12.42B	13.03B	13.84B	14.92B	16.14B	17.43B	18.56B	19.66B	21.04B	22.23B	23.32B	22.02B	21.19B	22.39B	22.71B	23.46B	24.45B	25.25B
Equity Average (Quarter)	8.83B	9.09B	9.36B	9.82B	10.50B	11.42B	12.48B	13.47B	14.17B	14.95B	15.99B	17.05B	18.06B	16.66B	15.20B	16.02B	16.45B	16.84B	17.25B	17.99B
Invested Capital (Quarter)	8.98B	9.20B	9.53B	10.66B	10.91B	11.93B	13.03B	14.38B	14.43B	15.47B	16.51B	18.01B	18.55B	14.77B	15.75B	16.53B	16.50B	17.18B	17.32B	18.67B
Asset Utilization Ratio (Quarter)	0.54	0.55	0.57	0.58	0.57	0.56	0.54	0.51	0.50	0.48	0.46	0.44	0.44	0.47	0.50	0.49	0.49	0.49	0.48	0.48
Leverage & Solvency
Interest Coverage Ratio (Quarter)										91.64	95.24	93.25	109.57	-355.02	148.84	366.43	210.03	311.11	359.45	365.42
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.74	0.75	0.76	0.75	0.77	0.77	0.78	0.77	0.76	0.76	0.76	0.77	0.78	0.73	0.70	0.73	0.72	0.71	0.70	0.73
Times Interest Earned (Quarter)										91.64	95.24	93.25	109.57	-355.02	148.84	366.43	210.03	311.11	359.45	365.42
Valuation
Enterprise Value (Quarter)	-6.92B	-6.71B	-6.96B	-7.52B	-8.24B	-9.25B	-9.77B	-10.78B	-10.41B	-11.24B	-11.93B	-11.22B	-10.17B	-5.80B	-6.52B	-6.12B	-6.20B	-6.38B	-6.29B	-6.61B
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	30.27%	21.95%	25.23%	25.56%	25.16%	33.00%	30.67%	29.33%	26.04%	24.31%	22.23%	20.51%	21.47%	-1.89%	-1.57%	-1.24%	-3.92%	20.31%	19.99%	19.51%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Vertex Pharmaceuticals Ratios (2009-2025) | VRTX

Create an account

Sign In

Reset Password